Beijing Savant Biotechnology Co.
Latest round
- Series C
Last raised
- Dec 2017
Total raised
- Undisclosed
Investors
- 6
About Beijing Savant Biotechnology Co.
,ltd is a chemiluminescent immunoreagents developer that provides in vitro diagnosis products. It is a National High Tech Enterprise.,ltd focuses on quantitative immunoassays and is engaged in the research, development, production and sales of in vitro diagnostic reagents and instruments. HuaKeTai has two major product lines which are chemiluminescence and POCT, with more than 260 industrial products. The products can be used in bone metabolism testing, liver fibrosis testing, diabetes testing, cardiac markers, tumour markers, and cytokine testing. The company also developed Magnetic Particle Fully Automatic Chemiluminescence Analyzer. The company generates revenue by producing tumour marker diagnostic reagents.
Who invested in Beijing Savant Biotechnology Co.
6 investors across 4 rounds
See all investors in Beijing Savant Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Beijing Savant Biotechnology Co.
Who invested in Beijing Savant Biotechnology Co.?
Beijing Savant Biotechnology Co. has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beijing Savant Biotechnology Co. raised?
Beijing Savant Biotechnology Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Beijing Savant Biotechnology Co. last raise money?
Beijing Savant Biotechnology Co.'s most recent round on record is a Series C, in Dec 2017.
What does Beijing Savant Biotechnology Co. do?
,ltd is a chemiluminescent immunoreagents developer that provides in vitro diagnosis products.
Where is Beijing Savant Biotechnology Co. headquartered?
Beijing Savant Biotechnology Co. is headquartered in Beijing, China.
Which VCs invest in companies like Beijing Savant Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Beijing Savant Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Beijing Savant Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.